CMS again declines coverage for NaF-PET scans

Despite numerous studies and years of research into the benefits of PET imaging with sodium fluoride (NaF) for cancer patients with bone metastases, the U.S. Centers for Medicare and Medicaid Services (CMS) has again rejected reimbursement coverage. {read more here}